A dual labelling method for measuring uptake of low molecular weight compounds into the pathogenic yeast Candida albicans

References

• Perfect JR. Fungal infections. Curr Opin Infect Dis 1992; 5: 433–436
   Web of Science ®Google Scholar
• Georgopapadakou NH, Walsh TJ. Human mycoses: drugs and targets for emerging pathogens. Science 1994; 264: 371–373
   PubMed Web of Science ®Google Scholar
• Beck-Sague CM, Jarvis WR, the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States 1980–1990. J Infect Dis 1993; 167: 1247–1251
   PubMed Web of Science ®Google Scholar
• Fisher-Hoch SP, Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis 1995; 21: 897–904
   PubMed Web of Science ®Google Scholar
• Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9: 499–511
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Wenzel RP. Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 1992; 11: 287–291
   PubMed Web of Science ®Google Scholar
• Pfaller MA. Epidemiology of candidiasis. J Hosp Infect 1995; 30: 329–338, (suppl)
   PubMed Web of Science ®Google Scholar
• Odds F. Epidemiological shifts in opportunistic and nosocomial Candida infections: mycological aspects. Int J Antimicrob Agents 1996; 6: 141–144
   PubMed Web of Science ®Google Scholar
• Herreros E, Garcia-Saez MI, Nombela C, Sanchez MA. A reorganized Candida albicans DNA sequence promoting homologous non-integrative genetic transformation. Mol Microbiol 1992; 6: 3567–3574
   PubMed Web of Science ®Google Scholar
• Dehoux P, Davies J, Cannon M. Natural cycloheximide resistance in yeast. The role of ribosomal protein L41. Eur J Biochem 1993; 213: 841–848
   PubMedGoogle Scholar
• Dick JD, Merz WG, Saral R. Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother 1980; 18: 158–163
   PubMed Web of Science ®Google Scholar
• Kawai S, Murao S, Mochizuki M, Shibuya I, Yano K, Takgi M. Drastic alteration of cycloheximide sensitivity by substitution of one amino acid in the L41 ribosomal protein of yeasts. J Bacteriol 1992; 174: 254–262
   PubMed Web of Science ®Google Scholar
• Balzi E, Wang M, Leterme S, Van Dyck L, Goffeau A. PDR5 a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J Biol Chem 1994; 269: 2206–2214
   PubMed Web of Science ®Google Scholar
• Bissinger PH, Kuchler K. Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance. J Biol Chem 1994; 269: 4180–4186
   PubMed Web of Science ®Google Scholar
• Nishi, K, Yoshida, M, Nishimura, M, et al. A leptomycin B resistance gene of Schizosaccharomyces pombe encodes a protein similar to the mammalian P-glycoproteins. Mol Microbiol 1992; 6: 761–769
   PubMed Web of Science ®Google Scholar
• Prasad R, Dewergifosse P, Goffeau A, Balzi E. Molecular cloning and characterization of a novel gene of Candida albicans CDR1 conferring multiple resistance to drugs and antifungals. Curr Genet 1995; 27: 320–329
   PubMed Web of Science ®Google Scholar
• Sanglard D, Ischer F, Monod M, Bille J. Susceptibilities of Candida albicans multidrug transporter mutants to various anti-fungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 1996; 40: 2300–2305
   PubMed Web of Science ®Google Scholar
• Sanglard D, Ischer F, Monod M, Bille J. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2 a new multidrug ABC transporter gene. Microbiology 1997; 143: 405–416
   PubMed Web of Science ®Google Scholar
• Ben-Yaacov R, Knoller S, Caldwell GA, Becker JM, Koltin Y. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Chemother 1994; 38: 648–652
   PubMed Web of Science ®Google Scholar
• Fling ME, Kopf J, Tamarkin A, Gorman JA, Smith HA, Koltin Y. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet 1991; 227: 318–329
   PubMedGoogle Scholar
• Jai Z-P, McCullough L, Wong L, Young PG. The amiloride resistance gene car1 of Schizosaccharomyces pombe. Mol Gen Genet 1993; 241: 298–304
   PubMedGoogle Scholar
• Kanazawa S, Driscoll M, Struhl K. ATR1 a Saccharomyces cerevisiae gene encoding a transmembrane protein required for aminotriazole resistance. Mol Cell Biol 1988; 8: 664–673
   PubMed Web of Science ®Google Scholar
• Sasnauskas K, Jomantiene R, Lebediene E, Lebedys J, Januska A, Janulaitis A. Cloning and sequence analysis of a Candida maltosa gene which confers resistance to cycloheximide. Gene 1992; 116: 105–108
   PubMed Web of Science ®Google Scholar
• Decottignies A, Kolackowski M, Balzi E, Goffeau A. Solubilization and characterization of the overexpressed PDR5 multi-drug resistance nucleotide triphosphatase of yeast. J Biol Chem 1994; 269: 12797–12803
   PubMed Web of Science ®Google Scholar
• Alarco AM, Balan I, Talibi D, Mainville N, Raymond M. AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily. J Biol Chem 1997; 272: 19304–19313
   PubMed Web of Science ®Google Scholar
• Hector RF. Compounds active against cell walls of medically important fungi. Clin Microbiol Rev 1993; 6: 1–21
   PubMed Web of Science ®Google Scholar
• Odds FC. Candida and Candidosis. WB Saunders, London 1988
   Google Scholar
• Nobel JG, Barnett JA. Passage of molecules through yeast cell walls: a brief essay-review. Yeast 1991; 7: 313–323
   PubMed Web of Science ®Google Scholar
• Poulain D, Cailliez JC, Dubremetz JF. Secretion of glycoproteins through the cell wall of Candida albicans. Eur J Cell Biol 1989; 50: 94–99
   PubMed Web of Science ®Google Scholar
• Gale EF. Nature and development of phenotypic resistance to amphotericin B in Candida albicans. Adv Microb Physiol 1986; 27: 278–321
   Web of Science ®Google Scholar
• Hitchcock CA, Russell NJ, Barrett-Bee KJ. Sterols in Candida albicans mutants resistant to polyene or azole antifungals and of a double mutant C albicans 64. Crit Rev Microbiol 1987; 15: 111–115
   PubMed Web of Science ®Google Scholar
• Hitchcock CA, Pye GW, Troke PF, Johnson EM, Warnock DW. Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother 1993; 37: 1962–1965
   PubMed Web of Science ®Google Scholar
• Odds FC. Resistance of yeasts to azole-derivative antifungals. J Antimicrob Chemother 1993; 31: 463–471
   PubMed Web of Science ®Google Scholar
• Hemmi K, Julmanop C, Hirata D, Tsuchiya E, Takemoto JY, Miyakawa T. The physiological roles of membrane ergosterol as revealed by the phenotypes of syr1/erg3 null mutant of Saccharomyces cerevisiae. Biosci Biotech Biochem 1995; 59: 482–486
   PubMed Web of Science ®Google Scholar
• Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 1995; 39: 2378–2386
   PubMed Web of Science ®Google Scholar
• Rottenberg H. The measurement of membrane potential and delta pH in cells organelles and vesicles. Meth Enzymol 1979; 55: 547–569
   PubMedGoogle Scholar
• Prasad R. Nutrient transport in Candida albicans a pathogenic yeast. Yeast 1987; 3: 209–221
   PubMed Web of Science ®Google Scholar
• Nikado H, Thanassi DG. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob Agents Chemother 1993; 37: 1393–1399
   PubMed Web of Science ®Google Scholar
• Davis R, Markham A, Balfour JA. Ciprofloxacin, an updated review of its pharmacology therapeutic efficacy and tolerability. Drugs 1996; 51: 1019–1074
   PubMed Web of Science ®Google Scholar
• Pleiss U, Conrad M, Baasner B. Synthesis of N-(4-(2-(24-Di-methylphenoxy)phenyl)- 2-thiazolyl)- hexahydro-2-pyrimidini-mine 14C) BAY w 6341. J Label Comp Radiopharmal 1995; 36: 275–279
   Web of Science ®Google Scholar
• Schaller K, Itayama H, Tiemann R, Uchida K, Yamaguchi H. Bay w 6341, a novel broad spectrum fungicidal agent impairs cell membrane function of Candida albicans. XIITH Congress of the International Society of Human And Animal Mycology (ISHAM), Adelaide, 1994
   Google Scholar
• Vry, J, Dietrich, H, Glaser, T, et al. BAY x3702 neuroprotectant (5-HT1A) agonist. Drugs Fut 1997; 22: 341–349
   Google Scholar
• Abram, TS, Boshagen, H, Butler, JE, et al. New structural analogue antagonist of peptido-leukotrienes. The discovery of BAY x7195. Bioorg Med Chem Lett 1993; 3: 1517–1522
   Web of Science ®Google Scholar
• Ziegelbauer K, Babcziuski P, Schonfeld W. Molecular mode of action of the antifungal β-amino acid BAY 10-8888. Antimicrob Agents Chemother 1998, in press
   Web of Science ®Google Scholar